In Digital Health Vitals, Episode 4, we break down the most important and controversial developments shaping digital health, AI in healthcare, and the business of care delivery — from startup bankruptcies to AI scribes and the monetization of clinical evidence driving the healthcare innovation ecosystem right now.

A fast-paced briefing on the latest AI and digital health developments shaping care and data.
We cover ChatGPT Health, AI prescription pilots, celebrity-driven GLP-1 programs, and ambient scribe studies, with practical takeaways for operators navigating evidence, ethics, and ROI in 2026.

The first episode of our new interview format features Halle Tecco, healthcare entrepreneur, investor, and author.

We dive into why healthcare is so hard to change, why many ideas fail, and what it truly takes to build innovation that works in the real world.

The final 2025 episode of Digital Health Vitals delivers a concise briefing for healthcare operators.
We cover key headlines and year-end highlights, giving a clear view of the market and what to watch in early 2026.

A monthly, operator-focused briefing highlighting the most important and actionable digital health news.
We cut through the noise to deliver practical insights on AI tools, platform dynamics, KPIs, and strategies clinics, payers, and health-tech teams can apply immediately.

A deep dive into why women’s health and femtech startups still face funding challenges in 2025.
We explore investor bias, regulatory hurdles, and systemic barriers, asking whether the funding gap for women-led teams is changing—or holding the ecosystem back.

A grounded discussion on longevity, separating real science from marketing hype as the field goes mainstream.
We explore what changed in recent years, key longevity metrics, the influencer effect, and where attention truly belongs—from lifestyle fundamentals to supplements and GLP-1 drugs.

A candid debate on whether value-based care is a real alternative to fee-for-service or an expensive illusion.
We examine what “value” really means, which metrics matter, and whether VBC success stories can truly scale beyond isolated cases.

An in-depth look at the crowded medical AI scribe market and why so many tools exist for the same problem.
We examine where the real innovation lies, the risks involved, and whether AI scribes truly move healthcare toward value-based care—or just attract VC hype.

A sharp debate on whether VC culture has harmed digital health, unpacking how aggressive investment tactics shape innovation, sustainability, and exits.

We explore the future of digital health funding and whether AI can help founders rely less on venture capital.